학술논문

The next milestone in clinical trial of a measurement system developed to diagnose NAFLD
Document Type
Conference
Source
2021 IEEE 21st International Symposium on Computational Intelligence and Informatics (CINTI) Computational Intelligence and Informatics (CINTI), 2021 IEEE 21st International Symposium on. :000199-000204 Nov, 2021
Subject
Bioengineering
Computing and Processing
Engineering Profession
Power, Energy and Industry Applications
Robotics and Control Systems
Signal Processing and Analysis
Pathology
Liver diseases
Biopsy
Liver
Bioimpedance
Clinical trials
Regulation
Non-alcoholic Fatty Liver Disease
bioimpedance spectrum measurement
clinical study
new diagnostic method
Language
ISSN
2471-9269
Abstract
Our publication presents the next important milestone in development of method aimed at the nondestructive diagnosis of Non-alcoholic Fatty Liver Disease (NAFLD). In clinical trials, a specific group of patients (with liver and other carcinomas) were studied. In their case, liver histological examinations are always carried out, which has given us the opportunity to compare bioimpedance spectrum (BIS) data with biopsy results. In our publication, we present the relevant measurement methodology after that we highlight some typical examples that describe the most common pathologies and their associated BIS origins.